Past ARM Events

The Alliance for Regenerative Medicine held a private reception for cell and gene therapy industry executives during Advanced Therapies Week on Wednesday, January 17, 2024 . Attendees enjoyed extensive networking opportunities with the sector’s top decision makers including executives from leading companies!

On November 1st, ARM convened key stakeholders from the Cell & Gene Therapy industry and held a Scientific Exchange meeting with FDA to improve the time and resource efficiency of development and regulatory review by leveraging elements that can serve as building blocks across programs.

The Alliance for Regenerative Medicine held a 1-day workshop on Tissue Engineering and Therapeutics on September 6, 2023, in the Rockville, MD area. This workshop highlighted scientific advances, CMC and regulatory insights, and funding perspectives.

The event will focus on the revision of the EU pharmaceuticals legislation and the EU Joint Clinical Assessment of ATMPs and how these policy initiatives will affect Europe’s competitiveness in the cell and gene therapy sector.

ARM and USP held a 1.5 day workshop on AAV Analytical Characterization on March 8-9, 2023, in the Washington DC area. This workshop covered various topics on AAV quality, including full / empty capsid characterization, potency assay, and titer measurements.

The Alliance for Regenerative Medicine and MEP Dr. Stelios Kympouropoulos held an event on November 29 at the European Parliament to outline how the EU can reverse its declining competitiveness and ensure patient access to transformative cell and gene therapies.

ARM will be hosting an information session on the upcoming 2023 GROW Internship Program cycle for member companies on Wednesday, November 9th at 1pm EST.

On October 19th, ARM and ASGCT will hold a meeting with FDA on the topic of potency assays for cell and gene therapies. The meeting will take place from 9 AM to 4 PM and will be live streamed for public viewing.